Medicare Delays Remote Patient Monitoring Ban to 2029, Leaving Hospitals Seeking Alternatives

The final rule prohibits hospitals from billing Medicare for RPM services furnished through external entities, requiring in-house delivery instead. This stems from concerns over billing integrity and direct supervision requirements, with regulators citing audits showing inconsistent documentation and potential overutilization. Hospitals argued the change disrupts established workflows that expanded access during the pandemic, particularly for chronic disease management in underserved areas.

Opposition included letters from the American Hospital Association and Remote Monitoring Leadership Council highlighting capacity gaps for smaller facilities. The two-year delay creates space for stakeholders to propose value-based alternatives, such as bundled payments tied to outcome metrics rather than fee-for-service codes. Related analyses from JAMA Health Forum on post-pandemic RPM utilization show mixed results on readmission reductions, underscoring the need for clearer evidence on scalable models.

Public health implications include potential access barriers for rural patients reliant on vendor-supported programs, amplifying disparities if in-house capabilities lag. CMS rationale emphasized program integrity over innovation speed, yet observational data from large health systems indicate vendor partnerships improved adherence tracking. Next steps involve stakeholder coalitions drafting guardrail proposals for 2027 rulemaking cycles.

Remaining questions center on whether the delay allows sufficient infrastructure buildout without compromising care continuity for high-risk populations.